Megace Related Published Studies
Well-designed clinical trials related to Megace (Megestrol)
[Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss]. [2011.07.23]
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17beta-estradiol (NOMAC/E2): a double-blind, randomized study. [2011.06]
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. [2011.05]
Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17beta-oestradiol: a double-blind, randomised, dose-finding pilot study. [2011.04]
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17beta-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study. [2011.03]
The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women. [2010.12]
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. [2010.10]
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care. [2010.04.13]
Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia. [2010.01]
Report of a Pilot, Double-Blind, Placebo-Controlled Study of Megestrol Acetate in Elderly Dialysis Patients With Cachexia. [2009.10.09]
Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. [2009.05]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer? [2008.12]
Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. [2008.11]
Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer? [2008.09.30]
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. [2008.04.01]
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). [2008]
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. [2007.02]
Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people. [2007.01]
Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. [2006]
Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. [2005.07]
The effects of megestrol acetate suspension for elderly patients with reduced appetite after hospitalization: a phase II randomized clinical trial. [2005.06]
Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period. [2005.06]
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. [2004.06.15]
Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months. [2004.03.15]
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. [2004]
Megestrol acetate-induced weight gain does not negatively affect blood lipids in elderly men: effects of resistance training and testosterone replacement. [2003.07]
Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. [2003.02]
Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. [2003]
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma. [2002.12]
Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses. [2002.07]
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. [2002.06]
Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. [2002.05]
Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. [2002.04.01]
Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. [2002.04]
Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. [2002.04]
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. [2002.01.15]
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. [2002.01]
[Clinical study on treatment of female idiopathic precocious puberty with combined therapy of Chinese medicine and megestrol acetate] [2001.10]
A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. [2001.08]
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. [2001.07.15]
The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. [2001.01]
Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. [2000.09]
Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study. [2000.05]
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. [2000.04]
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181. [2000.02.15]
Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. [2000]
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. [1999.10]
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK). [1999.06]
Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. [1999.04]
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. [1999.02]
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. [1999.01]
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group. [1999.01]
The dynamics of prostate specific antigen in hormone refractory prostate carcinoma: an analysis of cancer and leukemia group B study 9181 of megestrol acetate. [1998.11.01]
Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. [1998.10]
Sleep endocrine effects of megestrol acetate in healthy men. [1998.09]
Fadrozole versus megestrol acetate: a double-blind randomised trial in advanced breast cancer. [1998.09]
Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. [1998.08]
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. [1998.05.01]
Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. [1998.04]
Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma. [1998.02]
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK) [1997.06]
Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy. [1997.04]
The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. [1997.03.01]
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group. [1997.03]
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. [1997.02.15]
Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy. [1997.01]
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer. [1996.10]
[Observation on therapeutic effect of megestrol acetate on patients with chronic obstructive pulmonary disease at remission stage] [1996.07]
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. [1996.07]
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. [1996.06]
[Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study] [1996.03]
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185). [1996.02.01]
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. [1996.01]
Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07. [1995.04.30]
Pharmacokinetic evaluation of two different formulations of megestrol acetate in patients with advanced malignancies. [1995]
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. [1994.10]
Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. [1994.10]
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate. [1994.10]
Megestrol acetate in patients with AIDS and cachexia. [1994.09.15]
Megestrol acetate in patients with AIDS-related cachexia. [1994.09.15]
Megestrol acetate for the prevention of hot flashes. [1994.08.11]
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. [1993.11]
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. [1993.11]
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. [1993.04]
Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study. [1992.10]
Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection. [1992.07]
Megestrol acetate in cancer anorexia and weight loss. [1992.03.01]
High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer. [1992]
Megestrol acetate for anorexia and cachexia. [1992]
Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome. [1991.02]
Megestrol acetate in cancer cachexia. [1991.02]
Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy. [1990.12]
Appetite stimulation and weight gain with megestrol acetate. [1990.12]
Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection. [1990.12]
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. [1990.11]
A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. [1990.09.15]
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. [1990.08.15]
Megestrol acetate in cachectic patients with advanced bronchogenic cancer. [1990.08]
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. [1990.07.04]
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma. [1989.04]
|